个人科研网厅 | | 帮助
首都医科大学宣武医院知识库
高级检索
当前位置： 首页 > 详情页

Efficacy and cell-free DNA whole methylome based biomarker analysis of carboplatin plus taxanes neoadjuvant chemotherapy in triple negative breast cancer: A prospective multi-center cohort study

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：
Chen, X.[1] * ; Xiu, M.[2] ; Kang, H.[3] ; Zhang, Y.[4] ; Li, Q.[5] ; Cheng, X.[6] ; Wang, J.[7] ; Lan, B.[8] ; Chen, S.[2] ; Xiao, M.[1] ; Qian, X.[2] ; Hua, B.[9] ; Xu, B.[1] ; Zhang, P.[10] ;
机构： [1]Medical Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College - National Cancer Center, Cancer Hospital, Beijing, China [2]Department of medical Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College - National Cancer Center, Cancer Hospital, Beijing, China [3]Center for Thyroid and Breast Surgery, Department of General Surgery, Beijing Xuan Wu Hospital, Beijing, China [4]Center for Thyroid and Breast Surgery, Department of General Surgery, Xuanwu Hospital Capital Medical University, Beijing, China [5]Department of Medical Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College - National Cancer Center, Cancer Hospital, Beijing, China [6]Genecast Biotechnology, Genecast Biotechnology Co., Ltd., Beijing, China [7]Department of medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China [8]Medical Oncology Dept., Chinese Academy of Medical Sciences and Peking Union Medical College - National Cancer Center, Cancer Hospital, Beijing, China [9]Department of medical Oncology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China [10]oncology Department, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China
出处：
DOI： 10.1016/j.annonc.2024.08.272
ISSN：
语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2023]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
最新[2025]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
JCR分区：
出版当年[2022]版：
Q1 ONCOLOGY
最新[2023]版：
Q1 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者：
第一作者机构： [1]Medical Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College - National Cancer Center, Cancer Hospital, Beijing, China
推荐引用方式(GB/T 7714)：
Chen X.,Xiu M.,Kang H.,et al.Efficacy and cell-free DNA whole methylome based biomarker analysis of carboplatin plus taxanes neoadjuvant chemotherapy in triple negative breast cancer: A prospective multi-center cohort study[J].ANNALS OF ONCOLOGY.2024,35:S354-S354.doi:10.1016/j.annonc.2024.08.272.
APA：
Chen, X.,Xiu, M.,Kang, H.,Zhang, Y.,Li, Q....&Zhang, P..(2024).Efficacy and cell-free DNA whole methylome based biomarker analysis of carboplatin plus taxanes neoadjuvant chemotherapy in triple negative breast cancer: A prospective multi-center cohort study.ANNALS OF ONCOLOGY,35,
MLA：
Chen, X.,et al."Efficacy and cell-free DNA whole methylome based biomarker analysis of carboplatin plus taxanes neoadjuvant chemotherapy in triple negative breast cancer: A prospective multi-center cohort study".ANNALS OF ONCOLOGY 35.(2024):S354-S354

资源点击量：17236 今日访问量：0 总访问量：925 更新日期：2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持：重庆聚合科技有限公司 地址：北京市西城区长椿街45号宣武医院